Influenza A (H1N1) Vaccine

According to the mathematical model worked out by the U.S. Centers for Disease Control and Prevention, there should be about 1 million Americans infected with the H1N1 virus by now. However, those who have been infected with the virus showed mild symptoms and illness as well as a fairly quick recovery.

But, the virus seems to migrate from the Northern Hemisphere to the Southern Hemisphere, where the winter is about to start and the flu season is on the way. Nevertheless, “the virus is not mutating for the moment, it is stable.” Margaret Chan, Director General of the World Health Organization said in Moscow. Although the H1N1 infections seemed to be mild, it was also warned that medical professionals needed to do more protection on them so as to avoid getting infected with the virus. According to statistics, it was reported that a small number of health care workers have been infected with the virus while at work.

Meanwhile, China is now testing the vaccine for the influenza A (H1N1) and it is expected that the vaccine will be out in the market in September, just before the winter when another flu season will start. On the other hand, Swiss pharmaceuticals company Novartis AG said that it has successfully produced a first batch of swine flu vaccine weeks ahead of expectations.